Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report aims to provide a comprehensive presentation of the global market for Oncology Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Drugs. This report contains market size and forecasts of Oncology Drugs in global, including the following market information:
Global Oncology Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Drugs market was valued at US$ 203160 million in 2022 and is projected to reach US$ 392310 million by 2029, at a CAGR of 9.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
We surveyed the Oncology Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oncology Drugs Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Global Oncology Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oncology Drugs Market Segment Percentages, by Application, 2022 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
Global Oncology Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oncology Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Drugs, market overview.
Chapter 2: Global Oncology Drugs market size in revenue.
Chapter 3: Detailed analysis of Oncology Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oncology Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Drugs Overall Market Size
2.1 Global Oncology Drugs Market Size: 2022 VS 2029
2.2 Global Oncology Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Drugs Players in Global Market
3.2 Top Global Oncology Drugs Companies Ranked by Revenue
3.3 Global Oncology Drugs Revenue by Companies
3.4 Top 3 and Top 5 Oncology Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Drugs Players in Global Market
3.6.1 List of Global Tier 1 Oncology Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Drugs Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy (Biologic Therapy)
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type - Global Oncology Drugs Revenue & Forecasts
4.2.1 By Type - Global Oncology Drugs Revenue, 2018-2023
4.2.2 By Type - Global Oncology Drugs Revenue, 2024-2029
4.2.3 By Type - Global Oncology Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Drugs Market Size, 2022 & 2029
5.1.2 Blood Cancer
5.1.3 Breast Cancer
5.1.4 Gastrointestinal Cancer
5.1.5 Prostate Cancer
5.1.6 Respiratory or Lung Cancer
5.1.7 Others
5.2 By Application - Global Oncology Drugs Revenue & Forecasts
5.2.1 By Application - Global Oncology Drugs Revenue, 2018-2023
5.2.2 By Application - Global Oncology Drugs Revenue, 2024-2029
5.2.3 By Application - Global Oncology Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncology Drugs Market Size, 2022 & 2029
6.2 By Region - Global Oncology Drugs Revenue & Forecasts
6.2.1 By Region - Global Oncology Drugs Revenue, 2018-2023
6.2.2 By Region - Global Oncology Drugs Revenue, 2024-2029
6.2.3 By Region - Global Oncology Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncology Drugs Revenue, 2018-2029
6.3.2 US Oncology Drugs Market Size, 2018-2029
6.3.3 Canada Oncology Drugs Market Size, 2018-2029
6.3.4 Mexico Oncology Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncology Drugs Revenue, 2018-2029
6.4.2 Germany Oncology Drugs Market Size, 2018-2029
6.4.3 France Oncology Drugs Market Size, 2018-2029
6.4.4 U.K. Oncology Drugs Market Size, 2018-2029
6.4.5 Italy Oncology Drugs Market Size, 2018-2029
6.4.6 Russia Oncology Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Drugs Market Size, 2018-2029
6.4.8 Benelux Oncology Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncology Drugs Revenue, 2018-2029
6.5.2 China Oncology Drugs Market Size, 2018-2029
6.5.3 Japan Oncology Drugs Market Size, 2018-2029
6.5.4 South Korea Oncology Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Drugs Market Size, 2018-2029
6.5.6 India Oncology Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncology Drugs Revenue, 2018-2029
6.6.2 Brazil Oncology Drugs Market Size, 2018-2029
6.6.3 Argentina Oncology Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Drugs Revenue, 2018-2029
6.7.2 Turkey Oncology Drugs Market Size, 2018-2029
6.7.3 Israel Oncology Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Drugs Market Size, 2018-2029
6.7.5 UAE Oncology Drugs Market Size, 2018-2029
7 Oncology Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology Drugs Major Product Offerings
7.1.4 Roche Oncology Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Celgene
7.2.1 Celgene Company Summary
7.2.2 Celgene Business Overview
7.2.3 Celgene Oncology Drugs Major Product Offerings
7.2.4 Celgene Oncology Drugs Revenue in Global Market (2018-2023)
7.2.5 Celgene Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Oncology Drugs Major Product Offerings
7.3.4 Novartis Oncology Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Summary
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Oncology Drugs Major Product Offerings
7.4.4 Bristol-Myers Squibb Oncology Drugs Revenue in Global Market (2018-2023)
7.4.5 Bristol-Myers Squibb Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology Drugs Major Product Offerings
7.5.4 Johnson & Johnson Oncology Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Merck & Co.
7.6.1 Merck & Co. Company Summary
7.6.2 Merck & Co. Business Overview
7.6.3 Merck & Co. Oncology Drugs Major Product Offerings
7.6.4 Merck & Co. Oncology Drugs Revenue in Global Market (2018-2023)
7.6.5 Merck & Co. Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Oncology Drugs Major Product Offerings
7.7.4 AstraZeneca Oncology Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology Drugs Major Product Offerings
7.8.4 Pfizer Oncology Drugs Revenue in Global Market (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Amgen
7.9.1 Amgen Company Summary
7.9.2 Amgen Business Overview
7.9.3 Amgen Oncology Drugs Major Product Offerings
7.9.4 Amgen Oncology Drugs Revenue in Global Market (2018-2023)
7.9.5 Amgen Key News & Latest Developments
7.10 Eli Lilly
7.10.1 Eli Lilly Company Summary
7.10.2 Eli Lilly Business Overview
7.10.3 Eli Lilly Oncology Drugs Major Product Offerings
7.10.4 Eli Lilly Oncology Drugs Revenue in Global Market (2018-2023)
7.10.5 Eli Lilly Key News & Latest Developments
7.11 AbbVie
7.11.1 AbbVie Company Summary
7.11.2 AbbVie Business Overview
7.11.3 AbbVie Oncology Drugs Major Product Offerings
7.11.4 AbbVie Oncology Drugs Revenue in Global Market (2018-2023)
7.11.5 AbbVie Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Oncology Drugs Major Product Offerings
7.12.4 Takeda Oncology Drugs Revenue in Global Market (2018-2023)
7.12.5 Takeda Key News & Latest Developments
7.13 Astellas
7.13.1 Astellas Company Summary
7.13.2 Astellas Business Overview
7.13.3 Astellas Oncology Drugs Major Product Offerings
7.13.4 Astellas Oncology Drugs Revenue in Global Market (2018-2023)
7.13.5 Astellas Key News & Latest Developments
7.14 Ipsen
7.14.1 Ipsen Company Summary
7.14.2 Ipsen Business Overview
7.14.3 Ipsen Oncology Drugs Major Product Offerings
7.14.4 Ipsen Oncology Drugs Revenue in Global Market (2018-2023)
7.14.5 Ipsen Key News & Latest Developments
7.15 Sanofi
7.15.1 Sanofi Company Summary
7.15.2 Sanofi Business Overview
7.15.3 Sanofi Oncology Drugs Major Product Offerings
7.15.4 Sanofi Oncology Drugs Revenue in Global Market (2018-2023)
7.15.5 Sanofi Key News & Latest Developments
7.16 Bayer
7.16.1 Bayer Company Summary
7.16.2 Bayer Business Overview
7.16.3 Bayer Oncology Drugs Major Product Offerings
7.16.4 Bayer Oncology Drugs Revenue in Global Market (2018-2023)
7.16.5 Bayer Key News & Latest Developments
7.17 Biogen Idec
7.17.1 Biogen Idec Company Summary
7.17.2 Biogen Idec Business Overview
7.17.3 Biogen Idec Oncology Drugs Major Product Offerings
7.17.4 Biogen Idec Oncology Drugs Revenue in Global Market (2018-2023)
7.17.5 Biogen Idec Key News & Latest Developments
7.18 Teva
7.18.1 Teva Company Summary
7.18.2 Teva Business Overview
7.18.3 Teva Oncology Drugs Major Product Offerings
7.18.4 Teva Oncology Drugs Revenue in Global Market (2018-2023)
7.18.5 Teva Key News & Latest Developments
7.19 Otsuka
7.19.1 Otsuka Company Summary
7.19.2 Otsuka Business Overview
7.19.3 Otsuka Oncology Drugs Major Product Offerings
7.19.4 Otsuka Oncology Drugs Revenue in Global Market (2018-2023)
7.19.5 Otsuka Key News & Latest Developments
7.20 Eisai
7.20.1 Eisai Company Summary
7.20.2 Eisai Business Overview
7.20.3 Eisai Oncology Drugs Major Product Offerings
7.20.4 Eisai Oncology Drugs Revenue in Global Market (2018-2023)
7.20.5 Eisai Key News & Latest Developments
7.21 Merck KGaA
7.21.1 Merck KGaA Company Summary
7.21.2 Merck KGaA Business Overview
7.21.3 Merck KGaA Oncology Drugs Major Product Offerings
7.21.4 Merck KGaA Oncology Drugs Revenue in Global Market (2018-2023)
7.21.5 Merck KGaA Key News & Latest Developments
7.22 Gilead Sciences
7.22.1 Gilead Sciences Company Summary
7.22.2 Gilead Sciences Business Overview
7.22.3 Gilead Sciences Oncology Drugs Major Product Offerings
7.22.4 Gilead Sciences Oncology Drugs Revenue in Global Market (2018-2023)
7.22.5 Gilead Sciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Oncology Drugs Market Opportunities & Trends in Global Market
Table 2. Oncology Drugs Market Drivers in Global Market
Table 3. Oncology Drugs Market Restraints in Global Market
Table 4. Key Players of Oncology Drugs in Global Market
Table 5. Top Oncology Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Oncology Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Oncology Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Oncology Drugs Product Type
Table 9. List of Global Tier 1 Oncology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Oncology Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Oncology Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Oncology Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Oncology Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Oncology Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Oncology Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Oncology Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Oncology Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Oncology Drugs Product Offerings
Table 32. Roche Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Celgene Company Summary
Table 35. Celgene Oncology Drugs Product Offerings
Table 36. Celgene Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Celgene Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Oncology Drugs Product Offerings
Table 40. Novartis Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Bristol-Myers Squibb Company Summary
Table 43. Bristol-Myers Squibb Oncology Drugs Product Offerings
Table 44. Bristol-Myers Squibb Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Bristol-Myers Squibb Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Oncology Drugs Product Offerings
Table 48. Johnson & Johnson Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Merck & Co. Company Summary
Table 51. Merck & Co. Oncology Drugs Product Offerings
Table 52. Merck & Co. Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Merck & Co. Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Oncology Drugs Product Offerings
Table 56. AstraZeneca Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Oncology Drugs Product Offerings
Table 60. Pfizer Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Amgen Company Summary
Table 63. Amgen Oncology Drugs Product Offerings
Table 64. Amgen Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Amgen Key News & Latest Developments
Table 66. Eli Lilly Company Summary
Table 67. Eli Lilly Oncology Drugs Product Offerings
Table 68. Eli Lilly Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Eli Lilly Key News & Latest Developments
Table 70. AbbVie Company Summary
Table 71. AbbVie Oncology Drugs Product Offerings
Table 72. AbbVie Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. AbbVie Key News & Latest Developments
Table 74. Takeda Company Summary
Table 75. Takeda Oncology Drugs Product Offerings
Table 76. Takeda Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Takeda Key News & Latest Developments
Table 78. Astellas Company Summary
Table 79. Astellas Oncology Drugs Product Offerings
Table 80. Astellas Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Astellas Key News & Latest Developments
Table 82. Ipsen Company Summary
Table 83. Ipsen Oncology Drugs Product Offerings
Table 84. Ipsen Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Ipsen Key News & Latest Developments
Table 86. Sanofi Company Summary
Table 87. Sanofi Oncology Drugs Product Offerings
Table 88. Sanofi Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Sanofi Key News & Latest Developments
Table 90. Bayer Company Summary
Table 91. Bayer Oncology Drugs Product Offerings
Table 92. Bayer Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Bayer Key News & Latest Developments
Table 94. Biogen Idec Company Summary
Table 95. Biogen Idec Oncology Drugs Product Offerings
Table 96. Biogen Idec Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Biogen Idec Key News & Latest Developments
Table 98. Teva Company Summary
Table 99. Teva Oncology Drugs Product Offerings
Table 100. Teva Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Teva Key News & Latest Developments
Table 102. Otsuka Company Summary
Table 103. Otsuka Oncology Drugs Product Offerings
Table 104. Otsuka Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Otsuka Key News & Latest Developments
Table 106. Eisai Company Summary
Table 107. Eisai Oncology Drugs Product Offerings
Table 108. Eisai Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Eisai Key News & Latest Developments
Table 110. Merck KGaA Company Summary
Table 111. Merck KGaA Oncology Drugs Product Offerings
Table 112. Merck KGaA Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. Merck KGaA Key News & Latest Developments
Table 114. Gilead Sciences Company Summary
Table 115. Gilead Sciences Oncology Drugs Product Offerings
Table 116. Gilead Sciences Oncology Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Gilead Sciences Key News & Latest Developments
List of Figures
Figure 1. Oncology Drugs Segment by Type in 2022
Figure 2. Oncology Drugs Segment by Application in 2022
Figure 3. Global Oncology Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncology Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oncology Drugs Revenue in 2022
Figure 8. By Type - Global Oncology Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Oncology Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Oncology Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Oncology Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Oncology Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Oncology Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Oncology Drugs Revenue Market Share, 2018-2029
Figure 16. US Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Oncology Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Oncology Drugs Revenue Market Share, 2018-2029
Figure 28. China Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Oncology Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Oncology Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Oncology Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Celgene Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bristol-Myers Squibb Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Merck & Co. Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Pfizer Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Amgen Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Eli Lilly Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. AbbVie Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Takeda Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Astellas Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Ipsen Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Sanofi Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Bayer Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Biogen Idec Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Teva Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Otsuka Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Eisai Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Merck KGaA Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Gilead Sciences Oncology Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
